JP2024517600A5 - - Google Patents
Info
- Publication number
- JP2024517600A5 JP2024517600A5 JP2023562851A JP2023562851A JP2024517600A5 JP 2024517600 A5 JP2024517600 A5 JP 2024517600A5 JP 2023562851 A JP2023562851 A JP 2023562851A JP 2023562851 A JP2023562851 A JP 2023562851A JP 2024517600 A5 JP2024517600 A5 JP 2024517600A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- seq
- antigen
- antibody
- binding fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2021087278 | 2021-04-14 | ||
| CNPCT/CN2021/087278 | 2021-04-14 | ||
| PCT/CN2022/086525 WO2022218324A1 (en) | 2021-04-14 | 2022-04-13 | Novel anti-hvegfr2 antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024517600A JP2024517600A (ja) | 2024-04-23 |
| JP2024517600A5 true JP2024517600A5 (enExample) | 2025-04-21 |
Family
ID=83639492
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023562851A Pending JP2024517600A (ja) | 2021-04-14 | 2022-04-13 | 新規の抗ｈＶＥＧＦＲ２抗体 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240209099A1 (enExample) |
| EP (1) | EP4323408A4 (enExample) |
| JP (1) | JP2024517600A (enExample) |
| CN (1) | CN117177997A (enExample) |
| BR (1) | BR112023018537A2 (enExample) |
| CA (1) | CA3215430A1 (enExample) |
| TW (1) | TW202305002A (enExample) |
| WO (1) | WO2022218324A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118406145B (zh) * | 2024-05-29 | 2024-11-15 | 北京励和同创生物科技有限公司 | 一种抗磷酸化ASC_Tyr 144抗体及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002536968A (ja) * | 1999-01-29 | 2002-11-05 | イムクローン システムズ インコーポレイティド | Ｋｄｒに特異的な抗体およびその使用 |
| EP2298346A3 (en) * | 2002-03-04 | 2011-11-16 | Imclone LLC | Human antibodies specific to kdr and uses thereof |
| CN102093479B (zh) * | 2010-11-29 | 2012-10-03 | 侯宗柳 | 抗人血管内皮生长因子受体2的重组嵌合抗体 |
| EP2785742B1 (en) * | 2011-11-02 | 2020-01-08 | Apexigen, Inc. | Anti-kdr antibodies and methods of use |
| CA2868883C (en) * | 2012-03-30 | 2022-10-04 | Sorrento Therapeutics Inc. | Fully human antibodies that bind to vegfr2 |
| CN105646710B (zh) * | 2014-11-17 | 2020-08-25 | 四川科伦博泰生物医药股份有限公司 | 一种全人源化抗vegfr-2单克隆抗体及其制备方法 |
| CN106188296B (zh) * | 2016-07-19 | 2018-05-08 | 康融东方（广东）医药有限公司 | 一类抗血管内皮生长因子受体vegfr2的单克隆抗体及其编码基因和应用 |
| WO2021013064A1 (zh) * | 2019-07-19 | 2021-01-28 | 神州细胞工程有限公司 | 一种人源化vegfr2抗体及其应用 |
-
2022
- 2022-04-13 BR BR112023018537A patent/BR112023018537A2/pt unknown
- 2022-04-13 US US18/555,341 patent/US20240209099A1/en active Pending
- 2022-04-13 WO PCT/CN2022/086525 patent/WO2022218324A1/en not_active Ceased
- 2022-04-13 JP JP2023562851A patent/JP2024517600A/ja active Pending
- 2022-04-13 TW TW111113941A patent/TW202305002A/zh unknown
- 2022-04-13 EP EP22787546.5A patent/EP4323408A4/en active Pending
- 2022-04-13 CN CN202280028642.5A patent/CN117177997A/zh active Pending
- 2022-04-13 CA CA3215430A patent/CA3215430A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022515318A5 (enExample) | ||
| JP2020103301A5 (enExample) | ||
| JP2019500891A5 (enExample) | ||
| JP2022526764A5 (enExample) | ||
| JP2021521275A5 (enExample) | ||
| JP2023504016A5 (enExample) | ||
| JP2023539501A5 (enExample) | ||
| RU2017145150A (ru) | Антитело против pdl-1, его фармацевтическая композиция и применение | |
| JP2024504124A5 (enExample) | ||
| JP2026041845A5 (enExample) | ||
| JP2022525071A5 (enExample) | ||
| JP2023159379A (ja) | Ｐｄ－１とｖｅｇｆを標的とした四価二重特異性抗体、その製造方法および用途 | |
| JP2023550419A5 (enExample) | ||
| JP2024538669A5 (enExample) | ||
| JP2023516724A5 (enExample) | ||
| JP2021523949A5 (enExample) | ||
| JP2024513692A5 (enExample) | ||
| JP2022532991A5 (enExample) | ||
| IL301472A (en) | Specificity-enhanced bispecific antibody (SEBA) | |
| JP2023516941A5 (enExample) | ||
| JP2024532836A5 (enExample) | ||
| JP2024517600A5 (enExample) | ||
| JP2025503229A5 (enExample) | ||
| RU2019116638A (ru) | Биспецифические полипептиды к gitr и ctla-4 | |
| KR20260018083A (ko) | 항-fgfr2/pd-1 이중특이항체 |